Clinical practice guidelines for the use of recombinant and plasma-derived factor VIII and factor IX products
- MeSH Terms
- Factor XI Deficiency (C15.378.100.100.325); Factor X Deficiency (C15.378.100.100.320); Factor VII Deficiency (C15.378.100.100.310); Factor V Deficiency (C15.378.100.100.300); von Willebrand Diseases (C15.378.100.100.900); Blood Coagulation Disorders; Inherited (C15.378.100.100); Hemophilia B (C15.378.100.100.510); Hemophilia A (C15.378.100.100.500); Factor XIII Deficiency (C15.378.100.100.335); Factor XII Deficiency (C15.378.100.100.330)
- Guideline Contact
- Skye Newton ([email protected])
- Publication Scope
- management
- Countries of Application
- Australia
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- AHTA (AU)
- Publication Year
- 2005